Michael Torres
Chief Executive Officer CrossBridge Bio
Seminars
Wednesday 9th September 2026
Pharma Icebreaker Panel Discussion
7:45 am
- Understanding what it takes for pharma to invest. What are the current budgetary considerations within pharma?
- How is pharma assessing novel technologies, and where do they place within portfolios?
- What feels differentiated in a crowded space? From pharma’s perspective, what will make something best-in-class?
Wednesday 9th September 2026
2025/26 Deal-Making Highlights: How Did They Happen?
4:40 pm
- Representing examples of successful deal-making and successful management of alliances to foster future deals, what are the learnings?
- Sharing how early-stage programs can successfully navigate the “show me data” barrier with pharma, and the activation barrier to licencing technologies between equal sized biotech
- Debating recent regulatory and emerging technology shifts, and how these will shape licensing deals for the discussed modalities
